Literature DB >> 10231746

Pathological and physiological responses of ring-necked pheasant chicks following dietary exposure to the fungus Metarhizium flavoviride, a biocontrol agent for locusts in Africa.

J E Smits1, D L Johnson, C Lomer.   

Abstract

Metarhizium flavoviride, a fungal pathogen of grasshoppers and locusts, appears to be an effective, non-chemical insecticide (mycoinsecticide) for control of grasshoppers and locusts. This study, conducted during June and July, 1997, examined the pathogenic potential of this entomopathogenic fungus to non-target avian species that encounter infected insect prey items or contaminated food sources. Ring-necked pheasant (Phasianus colchicus) chicks were exposed to one of three diets, (spore-coated feed, infected insects, or untreated feed), either from 4 to 9 days of age, or, from 35 to 40 days of age. Necropsies were conducted on birds 10 days and 46 days old, respectively. Neither consumption of infected insects, nor of spore-coated feed, resulted in pathological changes, or significant changes in weight, growth rate, behavior, or mortality rate. Histological examination of organs indicated either no changes related to treatment, or normal tissue responses to antigenic challenge.

Entities:  

Mesh:

Year:  1999        PMID: 10231746     DOI: 10.7589/0090-3558-35.2.194

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  2 in total

Review 1.  Current Knowledge of the Entomopathogenic Fungal Species Metarhizium flavoviride Sensu Lato and Its Potential in Sustainable Pest Control.

Authors:  Franciska Tóthné Bogdányi; Renáta Petrikovszki; Adalbert Balog; Barna Putnoky-Csicsó; Anita Gódor; János Bálint; Ferenc Tóth
Journal:  Insects       Date:  2019-11-02       Impact factor: 2.769

2.  Increased and sex-selective avian predation of desert locusts Schistocerca gregaria treated with Metarhizium acridum.

Authors:  Wim C Mullié; Robert A Cheke; Stephen Young; Abdou Baoua Ibrahim; Albertinka J Murk
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.